Physician profile
Umar Shakur
NPI 1982799854
$4,480.84
in general payments reported to CMS, 2019-2025
35 companies · $1,646 in 2025
The $1,646 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.82 · 2022: $506 · 2023: $846 · 2024: $1,463 · 2025: $1,646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,955.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,954.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $911.81 | 2024-2025 | Gallant, Assurity, Xact |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $586.12 | 2022-2025 | Lifevest |
| Abiomed | $500.64 | 2023-2025 | Impella |
| Merck Sharp & Dohme LLC | $254.11 | 2022-2023 | Verquvo |
| Edwards Lifesciences Corporation | $237.39 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Novartis Pharmaceuticals Corporation | $235.97 | 2023-2025 | |
| Amgen INC. | $235.54 | 2024-2025 | Repatha, Repatha |
| Lantheus Medical Imaging, INC. | $169.38 | 2022-2025 | Definity |
| Bayer Healthcare Pharmaceuticals INC. | $139.48 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $133.63 | 2023-2025 | Farxiga, Brilinta |
| Janssen Pharmaceuticals, INC | $99.87 | 2023-2024 | Xarelto |
| Shockwave Medical, INC | $87.34 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Lexicon Pharmaceuticals, INC. | $75.07 | 2024 | |
| Endologix LLC | $69.32 | 2025 | Alto Abdominal Stent Graft System |
| E.R. Squibb & Sons, L.L.C. | $62.49 | 2019-2025 | Camzyos, Eliquis |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $60.71 | 2025 | Amvia Edge, Acticor 7 Vr-T Dx |
| Acist Medical Systems, INC. | $58.72 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.61 | 2024-2025 | Jardiance |
| Bracco Diagnostics INC. | $56.03 | 2022 | |
| Cleerly, INC. | $55.34 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Pfizer INC. | $46.87 | 2025 | |
| Penumbra, INC. | $45.97 | 2022-2025 | Indigo System |
| Vital Connect, INC | $38.57 | 2025 | Vitalpatch Rtm |
| Teleflex LLC | $35.85 | 2024 | Guideliner |
| Scpharmaceuticals INC. | $30.89 | 2024-2025 | |
| Inari Medical, INC. | $29.30 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $26.64 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Heartflow, INC. | $26.29 | 2024 | |
| Terumo Medical Corporation | $25.71 | 2023 | Metacross Otw, Glidewire, Heartrail |
| Boston Scientific Corporation | $19.55 | 2024 | Watchman Access System |
| Inspire Medical Systems, INC. | $18.72 | 2025 | Inspire |
| Thrombolex, INC. | $18.25 | 2025 | Bashir Endovascular Catheter |
| Medtronic, INC. | $16.79 | 2024 | Linq II |
| Kiniksa Pharmaceuticals, LTD. | $15.87 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Umar Shakur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.